Organon & Co | OGN - Чистый доход





Чистый доход Изменить Дата
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Celltrion KRW 8.88B 322.47B 2025-12
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Gilead Sciences USD 2.02B 162M 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Merck USD -4.24B 7.2B 2026-03
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Organigram Holdings CAD 19.97M 57.93M 2025-12
Organon & Co USD -205M 365M 2025-12
Ovoca Bio EUR -765K 4.89M 2025-06
Pharma Mar EUR 1.53M 58.13M 2026-03
Qiagen NV USD 107.83M 22.21M 2025-12
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -379.12M 25.12M 2025-12